What should be ordered next in a patient with hypercalcemia and a ureteral stone, in addition to treatment of the stone?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

In a patient with hypercalcemia and a ureteral stone, a comprehensive workup for primary hyperparathyroidism should be ordered next, in addition to treating the stone, and this should include ordering a Parathyroid hormone (PTH) level. This approach is based on the understanding that primary hyperparathyroidism is a significant cause of hypercalcemia and can lead to kidney stone formation due to increased urinary calcium excretion 1. The association between hypercalcemia and kidney stones is well-documented, with approximately 20% of patients with primary hyperparathyroidism developing kidney stones. Key considerations in the workup and management include:

  • Evaluating serum parathyroid hormone (PTH) levels to diagnose primary hyperparathyroidism
  • Assessing 24-hour urine calcium excretion to understand the impact on stone formation
  • Measuring serum phosphorus and vitamin D levels for a comprehensive metabolic evaluation
  • Referral to an endocrinologist and possibly a parathyroid surgeon if primary hyperparathyroidism is confirmed Other causes of hypercalcemia, such as malignancy, granulomatous diseases, and medication effects, should also be considered but are less common in outpatients with kidney stones and hypercalcemia compared to primary hyperparathyroidism 1. Given the potential for recurrent stone formation if the underlying hypercalcemia is not addressed, prioritizing the diagnosis and treatment of primary hyperparathyroidism is crucial 1.

From the Research

Next Steps in Diagnosis

In a patient with hypercalcemia and a ureteral stone, the following steps should be considered:

  • The most common cause of hypercalcemia is primary hyperparathyroidism, so assessing the level of parathyroid hormone (PTH) is crucial 2
  • Other basic investigations include plasma phosphorus level, vitamin D, and calculated creatinine clearance 2

Diagnostic Considerations

When evaluating hypercalcemia, it is essential to consider the following:

  • PTH-dependent hypercalcemia is mainly caused by primary hyperparathyreosis 2
  • If PTH is suppressed, malignant disease must be considered carefully 2
  • The diagnosis of primary hyperparathyroidism (PHPT) is confirmed in the presence of hypercalcemia and a normal or elevated PTH level in the absence of conditions that mimic PHPT 3

Laboratory Tests

The following laboratory tests may be ordered:

  • Parathyroid hormone (PTH) level to assess for primary hyperparathyroidism 2, 3
  • Serum calcium and phosphorus levels to evaluate the severity of hypercalcemia
  • Vitamin D level to assess for vitamin D-mediated hypercalcemia 4, 5
  • 1,25-Dihydroxyvitamin D level to evaluate for vitamin D-mediated hypercalcemia 5

Answer

Based on the provided evidence, the most appropriate next step would be to order: A. Parathyroid hormone (PTH) level to assess for primary hyperparathyroidism, as it is the most common cause of hypercalcemia 2, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Hypercalcemia].

Duodecim; laaketieteellinen aikakauskirja, 2014

Research

Medical management of primary hyperparathyroidism.

Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry, 2013

Research

Hypercalcemia of malignancy with simultaneous elevation in serum parathyroid hormone--related peptide and 1,25-dihydroxyvitamin D in a patient with metastatic renal cell carcinoma.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.